Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Tsoi

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|February 21, 2022
High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass CytometryGloria Yiu, Tue Kruse Rasmussen, Brandon L Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
CTLA4 blockade broadens the peripheral T-cell receptor repertoireLidia Robert, Jennifer Tsoi, Xiaoyan Wang, et al.
Molecular Cancer|July 3, 2015
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Molecular Cancer|August 22, 2014
Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Science (New York, N.Y.)|November 27, 2020
Precise T cell recognition programs designed by transcriptionally linking multiple receptorsJasper Z Williams, Greg M Allen, Devan Shah, et al.
Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.
Cancer Immunology Research|September 4, 2016
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T CellsBlanca Homet Moreno, Jesse M Zaretsky, Angel Garcia-Diaz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistanceYapeng Su, Wei Wei, Lidia Robert, et al.
Nature Medicine|July 4, 2019
Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanomaAntoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
Nature Medicine|June 8, 2019
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanomaAntoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|February 21, 2022
High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass CytometryGloria Yiu, Tue Kruse Rasmussen, Brandon L Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
CTLA4 blockade broadens the peripheral T-cell receptor repertoireLidia Robert, Jennifer Tsoi, Xiaoyan Wang, et al.
Molecular Cancer|July 3, 2015
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Molecular Cancer|August 22, 2014
Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Science (New York, N.Y.)|November 27, 2020
Precise T cell recognition programs designed by transcriptionally linking multiple receptorsJasper Z Williams, Greg M Allen, Devan Shah, et al.
Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.
Cancer Immunology Research|September 4, 2016
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T CellsBlanca Homet Moreno, Jesse M Zaretsky, Angel Garcia-Diaz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2017
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistanceYapeng Su, Wei Wei, Lidia Robert, et al.
Nature Medicine|July 4, 2019
Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanomaAntoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
Nature Medicine|June 8, 2019
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanomaAntoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
Pageof 4